Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia. [electronic resource]
Producer: 20090408Description: 627-9 p. digitalISSN:- 1476-5551
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Asparaginase -- administration & dosage
- Combined Modality Therapy
- Cytarabine -- administration & dosage
- Dasatinib
- Daunorubicin -- administration & dosage
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- In Situ Hybridization, Fluorescence
- Male
- Methotrexate -- administration & dosage
- Mitoxantrone -- administration & dosage
- Neoplasm Proteins -- analysis
- Neutropenia -- chemically induced
- Oncogene Proteins, Fusion -- analysis
- Peripheral Blood Stem Cell Transplantation
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma -- complications
- Prednisone -- administration & dosage
- Pyrimidines -- therapeutic use
- Remission Induction
- Splenic Rupture -- etiology
- Thiazoles -- therapeutic use
- Vincristine -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.